A Study of Indoximod in Combination With (7+3) Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia

NCT02835729 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Idarubicin
DRUG: Cytarabine
DRUG: Indoximod Freebase
DRUG: Indoximod HCL F1
DRUG: Indoximod HCL F2

Sponsor

NewLink Genetics Corporation